News & Events

Giulia Luraghi won this award "ESB-ITA Best in silico model for industrial translation via on" in an Italian conference. 

Read more ...

VPHi - Sign our petition to promote adoption of in silico trials!

Read more ...

 white paper

The INSIST Clinical Focus Group Discussions produced a Whitepaper!

In April 2019 Clinical Focus Group Discussions were organized to inform interested clinicians and to obtain their feedback on the concept, current state of the art, and intended further development of the INSIST project. 

Read the whole paper here

There was a presentation of WP5 work at a mini-symposium of INSIST at the third ESM-EVBO conference in Maastricht, The Netherlands (April 15th-18th 2019) 

Read more ...

One of our partners in the consortium, UvA, is part of the CompBioMed project, which has worked with others on generating a beautiful movie on "The virtual Human".

Read more ...


The INSIST consortium is the result of a truly multi-disciplinary and multi-sectorial effort. It is headed by an interventional neuroradiologist and combines the knowledge of multiple experts in computational science, biology, biophysics, biomedical engineering, epidemiology, and radiological, neurological, and cardiovascular clinical research. The crucial involvement of academic and large teaching hospitals will secure access to patient data and clinical expertise. This will ensure that the in silico tools resulting from this project have a direct impact in the clinic. All the relevant end users (neurologists and intervention radiologists, as well as device- and pharma industry) are member of the INSIST consortium and involved in the entire process to ensure a successful and relevant development of the in silico tools. 


At the kick-off meeting we organised a minisymposium; Basic Overview of Acute Ischemic Stroke, current state of art, running trials where the main clinicians involved in INSIST presented.

These presentations can be seen below:


Epidemiology, clinical scores, IVT: Yvo Roos


Imaging: Aad van der Lugt


Endovascular treatment: Charles Majoie


Running trials (CONTRAST): Diederik Dippel